A carregar...
Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years
BACKGROUND: Age is a major risk factor for herpes zoster (HZ) and its potential long-term complication post-herpetic neuralgia (PHN). Due to the significant burden of HZ and PHN on patients' quality of life, it is vital that effective and well-tolerated vaccines are available to prevent HZ in o...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3256327/ https://ncbi.nlm.nih.gov/pubmed/21941091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.7.10.16480 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|